Bacteremia – pipeline review, h1 2012


Published on

Aarkstore Enterprise-Bacteremia – Pipeline Review, H1 2012 || Market Research latest report

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Bacteremia – pipeline review, h1 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Bacteremia – Pipeline Review, H1 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s, Bacteremia - Pipeline Review, H1 2012, provides anoverview of the Bacteremia therapeutic pipeline. This report provides informationon the therapeutic development for Bacteremia, complete with latest updates, andspecial features on late-stage and discontinued projects. It also reviews key playersinvolved in the therapeutic development for Bacteremia. Bacteremia - PipelineReview, H1 2012 is built using data and information sourced from Global MarketsDirect’s proprietary databases, Company/University websites, SEC filings, investorpresentations and featured press releases from company/university sites andindustry-specific third party sources, put together by Global Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Bacteremia.- A review of the Bacteremia products under development by companies anduniversities/research institutes based on information derived from company andindustry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.- A feature on pipeline projects on the basis of monotherapy and combined
  2. 2. therapeutics.Table of contents:List of Tables 4List of Figures 4Introduction 5Global Markets Direct Report Coverage 5Bacteremia Overview 6Therapeutics Development 7An Overview of Pipeline Products for Bacteremia 7Bacteremia Therapeutics under Development by Companies 9Bacteremia Therapeutics under Investigation by Universities/Institutes 10Mid Clinical Stage Products 11Comparative Analysis 11Early Clinical Stage Products 12Comparative Analysis 12Bacteremia Therapeutics – Products under Development by Companies 13Bacteremia Therapeutics – Products under Investigation by Universities/Institutes14Companies Involved in Bacteremia Therapeutics Development 15Trius Therapeutics, Inc. 15Bacteremia – Therapeutics Assessment 16Assessment by Monotherapy Products 16Assessment by Combination Products 17Assessment by Route of Administration 18Assessment by Molecule Type 20Drug Profiles 22Oritavancin - Drug Profile 22Product Description 22Mechanism of Action 22R&D Progress 22Tedizolid Phosphate - Drug Profile 24Product Description 24Mechanism of Action 24R&D Progress 24
  3. 3. N-acetylcystein + Tigecycline + Heparin - Drug Profile 25Product Description 25Mechanism of Action 25R&D Progress 25Daptomycin - Drug Profile 26Product Description 26List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H1 2012 Review, H12012&PubId=&pagenum=1Bacteremia – Pipeline Review, H1 2012Staphylococcus Aureus Infections – Pipeline Review, H1 2012Warts – Pipeline Review, H1 2012Mixed Dyslipidemia – Pipeline Review, H1 2012Gastroenteritis – Pipeline Review, H1 2012Hypereosinophilic Syndrome – Pipeline Review, H1 2012Familial Adenomatous Polyposis Coli – Pipeline Review, H1 2012
  4. 4. Tinnitus – Pipeline Review, H1 2012Shock – Pipeline Review, H1 2012Influenza B Infections – Pipeline Review, H1 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: